GGrantIndex
Sort

53,477 grants matching addiction

Training and Education

$494,247
Stanton Arnold Glantz · University Of California, San Francisco · P50 · FY2017 · CA

Environment Cue-Reactivity: Brain, Behavior and Clinical Outcomes in Tobacco Use

$494,216
Francis Joseph McClernon · Duke University · R01 · FY2017 · DA

Evaluation of Drug Checking as a Novel Intervention to Address the Opioid Overdose Crisis Attributable to Fentanyl and its Analogues

$494,190
Lianping Ti · University Of British Columbia · R01 · FY2023 · DA

Evaluation of Drug Checking as a Novel Intervention to Address the Opioid Overdose Crisis Attributable to Fentanyl and its Analogues

$494,190
Evan Wood · University Of British Columbia · R01 · FY2022 · DA

Correlates and outcomes of opioid dose escalation among chronic pain patients

$494,186
Benjamin J. Morasco · Oregon Health & Science University · R01 · FY2015 · DA

Targeting replication stress avoidance in cancer

$494,159
Sharon B Cantor · Univ Of Massachusetts Med Sch Worcester · R01 · FY2020 · CA

Marijuana's Impact on Alcohol Motivation and Consumption

$494,150
Jane Metrik · Brown University · R01 · FY2017 · AA

Marijuana's Impact on Alcohol Motivation and Consumption

$494,143
Jane Metrik · Brown University · R01 · FY2018 · AA

Marijuana's Impact on Alcohol Motivation and Consumption

$494,137
Jane Metrik · Brown University · R01 · FY2019 · AA

Epigenetic Biomarkers of Early Psychotropic Medication Exposure

$494,115
Alicia K Smith · Emory University · RC1 · FY2009 · MH

Integrated Drug and Medical Care-Cost and Effectiveness

$494,092
Constance M. Weisner · University Of California, San Francisco · R37 · FY2009 · DA

Optimization of novel thioesters as a therapeutic strategy for combating opioid overdoses and abuse

$494,069
Stephen John Lewis · Case Western Reserve University · U01 · FY2020 · DA

Metabolic basis of ARID1A-mutated ovarian cancer

$494,032
Rugang Zhang · University Of Tx Md Anderson Can Ctr · R01 · FY2025 · CA

Developing a Music Listening mHealth Intervention for Stress Reduction in Early Recovery

$493,994
Michael Cleveland · Washington State University · R61 · FY2025 · AA

Studies in Cocaine Abuse

$493,987
Gene-Jack Wang · Brookhaven Science Assoc-Brookhaven Lab · R01 · FY2011 · DA

A Clinical Laboratory with Integrated Neuroscience (CLIN) for Early Evaluation of Medications for Substance Use Disorders

$493,985
Kyle Matthew Kampman · University Of Pennsylvania · UG1 · FY2024 · DA

Behavioral Drug and HIV Risk Reduction Counseling with MMT in China

$493,920
Marek C Chawarski · Yale University · R01 · FY2013 · DA

Functional Consequences of Putative Pharmacotherapies for Cocaine Dependence in A

$493,904
Linda J. Porrino · Wake Forest University Health Sciences · P50 · FY2012 · DA

Cholinergic regulation of striatal neurochemistry in cue-triggered decision-making

$493,867
Sean Bjorn Ostlund · University Of California-Irvine · R01 · FY2017 · MH

Developing a Consumer Guide to Adolescent Drug Treatment

$493,830
John S Cacciola · Treatment Research Institute · P50 · FY2012 · DA

Investigating the role of metabolic rewiring in breast tumor innervation

$493,795
Younghye Song · University Of Arkansas At Fayetteville · R37 · FY2025 · CA

Training Program: Drugs of Abuse & Related Neuropeptides

$493,747
Ellen M Unterwald · Temple Univ Of The Commonwealth · T32 · FY2016 · DA

Relationship Dynamics and Young Adult Drug Use and Abuse

$493,729
Phuong Thao Ha · Arizona State University-Tempe Campus · R01 · FY2016 · AA

Yale BIRCWH Scholar Program on Women's Health and Addictive Behaviors

$493,718
Carolyn M Mazure · Yale University · K12 · FY2012 · DA

Yale BIRCWH Scholar Program on Women's Health and Addictive Behaviors

$493,718
Carolyn M Mazure · Yale University · K12 · FY2011 · DA